HealthDay News — For young adults without known risk factors, a one-time routine HIV screen at 25 years would optimize clinical outcomes and be cost-effective, according to a study published in the Journal of Adolescent Health.

Anne M. Neilan, MD, MPH, from Massachusetts General Hospital in Boston, and colleagues simulated HIV-uninfected 12-year-olds without identified risk factors who faced age-specific HIV infection risks. The authors modeled a one-time HIV screen ($36) at age 15, 18, 21, 25, or 30 years, each in addition to current US screening practices (30% screened by age 24).

The researchers found that all one-time screens detected a small proportion of lifetime infections (0.1% to 10.3%). 

A screen at 25 years led to the most favorable care continuum outcomes at age 25 compared to current screening practices, with a higher proportion diagnosed (77% vs 51%), linked to care (71% vs 51%), retained in care (68% vs 44%), and virologically suppressed (49% vs 32%). A screen at age 25 years not only provided the greatest clinical benefit but also was cost-effective ($96,000/year-of-life saved [YLS]) by US standards of <$100,000/YLS compared with the next most effective screen.

“Focusing screening on adolescents and young adults ages 18 or younger is a less efficient use of a one-time screen among AYA than screening at a later age,” the authors write.

Related Articles

Reference

Neilan Am, Dunville R, Ocfemia MCB, et al. The optimal age for screening adolescents and young adults without identified risk factors for HIV. J Adolesc Health. 2018 Jan;62(1):22-28.